CS227791A3 - Mutant of clostridium histolyticum bacterium, process of its obtaining and its application for the production of collagenase without clostripain - Google Patents

Mutant of clostridium histolyticum bacterium, process of its obtaining and its application for the production of collagenase without clostripain Download PDF

Info

Publication number
CS227791A3
CS227791A3 CS912277A CS227791A CS227791A3 CS 227791 A3 CS227791 A3 CS 227791A3 CS 912277 A CS912277 A CS 912277A CS 227791 A CS227791 A CS 227791A CS 227791 A3 CS227791 A3 CS 227791A3
Authority
CS
Czechoslovakia
Prior art keywords
collagenase
clostripain
mutant
clostridium
clostridium histolyticum
Prior art date
Application number
CS912277A
Other languages
Czech (cs)
English (en)
Inventor
Milan Holjevac
C Ivan Udovici
Sonja Cizmek
Vlasta Sojak-Derkos
Stjepan Gamulin
C Vladimir Deli
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Publication of CS227791A3 publication Critical patent/CS227791A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/145—Clostridium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/842—Clostridium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS912277A 1990-07-23 1991-07-22 Mutant of clostridium histolyticum bacterium, process of its obtaining and its application for the production of collagenase without clostripain CS227791A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU144090 1990-07-23

Publications (1)

Publication Number Publication Date
CS227791A3 true CS227791A3 (en) 1992-03-18

Family

ID=25554178

Family Applications (1)

Application Number Title Priority Date Filing Date
CS912277A CS227791A3 (en) 1990-07-23 1991-07-22 Mutant of clostridium histolyticum bacterium, process of its obtaining and its application for the production of collagenase without clostripain

Country Status (10)

Country Link
US (1) US5252481A (fr)
EP (1) EP0468411B1 (fr)
JP (1) JPH05219942A (fr)
AT (1) ATE130867T1 (fr)
BG (1) BG94868A (fr)
CA (1) CA2047306A1 (fr)
CS (1) CS227791A3 (fr)
DE (1) DE69114935T2 (fr)
HU (1) HU912453D0 (fr)
PL (1) PL291186A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332503A (en) * 1993-04-16 1994-07-26 Baxter International Inc. Process for purifying collagenase
DE19521829A1 (de) * 1995-06-16 1996-12-19 Knoll Ag Neue Verwendung von Collagenase
KR100246820B1 (ko) * 1997-12-30 2000-03-15 정수련 신균주 트리고높시스 배리아빌리스에 의한 에리쓰리톨의 제조방법
US6001616A (en) * 1998-09-16 1999-12-14 Dong Cheon Consulting Co., Ltd. Process for preparing erythritol using novel cell of pichia
US7811560B2 (en) * 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
EP2130551B1 (fr) * 2008-06-02 2012-06-06 Roche Diagnostics GmbH Purification améliorée de collagénases à partir de culture liquide de Clostridium histolyticum
US10119131B2 (en) 2011-03-16 2018-11-06 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
ES2968836T3 (es) 2012-01-12 2024-05-14 Endo Global Ventures Enzima del clostridium histolyticum
US9744138B2 (en) 2013-03-15 2017-08-29 Biospecifics Technologies Corp. Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
IL301796A (en) 2017-03-01 2023-05-01 Endo Ventures Ltd A method for evaluating and treating cellulite
WO2018183582A2 (fr) 2017-03-28 2018-10-04 Endo Ventures Limited Procédé de production de collagénase amélioré
CZ308157B6 (cs) 2017-09-13 2020-01-29 MB PHARMA s.r.o. Kmen bakterie Clostridium histolyticum, kolagenáza připravená s použitím tohoto kmene a její použití
EP4045078A1 (fr) 2019-10-15 2022-08-24 The Johns Hopkins University Traitement de fibromes utérins à l'aide de collagénase purifiée

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3201325A (en) * 1963-02-15 1965-08-17 Miles Lab Process for the recovery of collagenase
US3821364A (en) * 1966-07-08 1974-06-28 Advance Biofactures Corp Process of producing collagenase
US3705083A (en) * 1966-07-08 1972-12-05 Agricultural Biolog Corp Process for producing collagenase
US3677900A (en) * 1970-05-04 1972-07-18 Univ Lehigh Method of producing collagenase with a species of vibrio
FR2474052B1 (fr) * 1980-01-21 1984-04-20 Agronomique Inst Nat Rech Nouvelle collagenase, procede d'obtention et applications

Also Published As

Publication number Publication date
EP0468411A2 (fr) 1992-01-29
US5252481A (en) 1993-10-12
HU912453D0 (en) 1991-12-30
BG94868A (bg) 1993-12-24
EP0468411B1 (fr) 1995-11-29
PL291186A1 (en) 1992-11-02
DE69114935T2 (de) 1996-05-30
ATE130867T1 (de) 1995-12-15
EP0468411A3 (en) 1992-09-23
JPH05219942A (ja) 1993-08-31
DE69114935D1 (de) 1996-01-11
CA2047306A1 (fr) 1992-01-24

Similar Documents

Publication Publication Date Title
Abdel-Fattah et al. Biodegradation of feather waste by keratinase produced from newly isolated Bacillus licheniformis ALW1
Nam et al. Native-feather degradation by Fervidobacterium islandicum AW-1, a newly isolated keratinase-producing thermophilic anaerobe
Tran et al. Isolation and characteristics of Bacillus subtilis CN2 and its collagenase production
CS227791A3 (en) Mutant of clostridium histolyticum bacterium, process of its obtaining and its application for the production of collagenase without clostripain
Chandrasekaran et al. Exploring the in vitro thrombolytic activity of nattokinase from a new strain Pseudomonas aeruginosa CMSS
Batish et al. Studies on environmental and nutritional factors on production of antifungal substance byLactobacillus acidophilus R.
KR100413335B1 (ko) 항균 펩타이드 물질을 생산하는 유산균 락토코커스 락티스bh5(케이씨씨엠 10275)
AU615661B2 (en) Acid urease and production thereof
Wang et al. Production of antifungal materials by bioconversion of shellfish chitin wastes fermented by Pseudomonas fluorescens K-188
Hassan et al. Amylase production, purification and characterization from Escherichia coli
CZ308157B6 (cs) Kmen bakterie Clostridium histolyticum, kolagenáza připravená s použitím tohoto kmene a její použití
Cortezi et al. Characterization of a feather degrading by Bacillus amyloliquefaciens protease: a new strain
Omran Production of keratinases from Nocardiopsis sp. 28ROR as a novel Iraqi strain
Lehrer et al. Isolation and purification of endotoxin by hydrolytic enzymes
US3767533A (en) Process for producing uricase
Rosenkranz Unusual alkaline phosphatase levels in streptomycin-dependent strains of E. coli
US3345269A (en) Process for the production of proteolytic enzymes
RU2193063C2 (ru) Бактериолитический комплекс, способ его получения и штамм для осуществления способа
Jois et al. STUDY ON PRODUCTION, PURIFICATION AND CHARACTERISATION OF L-ASPARAGINASE FROM ESCHERICHIA COLI AND PSEUDOMONAS AERUGINOSA.
JP2898022B2 (ja) コラーゲン分解酵素の製造方法
KR0183318B1 (ko) 바실러스속 미생물을 이용한 폐수처리방법
RU2726653C2 (ru) Штамм бактерий Lactobacillus salivarius - продуцент ингибитора цитокинов интерлейкина-6 и интерлейкина-17
HRP920480A2 (en) Clostridium histolyticum bacterium mutant, its use for aring collagenase enzymes without clostripaine
JP2630391B2 (ja) ラクトバチルスに属する新菌種並びにその分離増殖方法
KR100376562B1 (ko) 비스루트균의 생산성을 향상시키는 방법